Revolutionizing Heart Health: The SCAPIS Study Aims to Prevent Heart Attacks
Every year, approximately 8,000 individuals under the age of 70 experience their first heart attack, leading to over 1,000 tragic fatalities. To combat this alarming trend, Göran Bergström, the chief physician at Sahlgrenska University Hospital in Gothenburg, has set an ambitious goal to significantly reduce the number of people affected by heart disease by the year 2030.
At the forefront of this initiative is SCAPIS, the world's largest heart study, for which Göran Bergström serves as the scientific head. This groundbreaking research project is a collaborative effort involving six universities and university hospitals across Sweden, targeting 30,000 residents to investigate heart, blood vessel, and lung health. The ultimate aim is to develop predictive measures and preventive strategies for heart and lung diseases.
"My focus is to try to identify individuals who appear healthy but may be at significant risk of a heart attack without their knowledge," says Bergström. With high hopes for identifying these 'silent risks', he emphasizes the need for innovative tools capable of revealing potential threats to heart health.
In the SCAPIS study, researchers are meticulously examining the hearts and blood vessels of 30,000 participants to determine any subtle changes indicative of heart attack risk. Alarmingly, over 40 percent of those examined demonstrated some degree of change; while many showed only minor alterations, one in twenty had significant issues without being aware. Such extensive evaluations are costly, but ongoing research promises advancements in technology that may allow risk identification through simpler methods, such as a blood test.
"If we can identify these high-risk individuals, we can offer preventive assistance that typically involves lifestyle modifications and effective medications," explains Bergström. Currently, many tools exist to assist those already at risk, but the primary challenge remains: finding those who are unaware of their potential dangers.
Göran Bergström believes the key to timely intervention lies in discovering an efficient, cost-effective method of screening. "Perhaps we can develop a blood test that is not just reliable but also affordable, enabling us to pinpoint high-risk individuals swiftly. If SCAPIS can unveil a smart and economical screening process, I would aim to reduce the number of at-risk individuals by 20 to 30 percent," he states.
Conducting a study as extensive as SCAPIS requires substantial financial resources. The Heart-Lung Foundation is the primary financier, emphasizing that every donation counts toward advancing critical heart research. "We can monitor various blood markers in our participants, but we currently lack the funding to measure everything we aspire to. I am confident that solutions will emerge soon, but it is the financial support that will allow us to take these necessary steps forward," Bergström concludes.
To help prevent heart attacks and support this vital research, consider contributing to the SCAPIS initiative. Every contribution makes a difference in the quest to safeguard heart health.
Related Sources: